REFERENCES
- Kessler DA. Addressing the problem of misleading advertisements. Ann Intern Med 1992;116:950–1.
- Beary 1111F Letter. Ann Intern Med 1992;117:616.
- Angel JF. Letter. Ann Intern Med 1992;117:616–7.
- Liebman M. Letter. Ann Intern Med 1992;117: 617.
- Rubenstein DS. Letter. Ann Intern Med 1992;116:958.
- Flick E, Antonelli MA. Letter. An Intern Med 1992;116:958.
- Wilkes MS, Doblin B, Shapiro M. Pharmaceutical advertisements in lead-ing medical journals: experts' assessments. Ann Intern Mod 1992;116:912–9.
- 15 U.S.C. ¢§ 45(a) and 52 (1988).
- Day R.L. ". . . Up to eight hours of relief......J Am Pharm Assoc 1976;NS16:496+.
- Cope 1D. The charges against OTC medicine advertising-are they de-served? J Am Pharm Assoc 1976;NSI6:500–4.
- Hodes B. Are magazine ads for OTC drugs based on fact? J Am Pharm Assoc 1976;NSI6:513–5.
- Cope 1D. Nonprescription drugs and the regulation of advertising. 1 Drug Issues I992;22(2):257–64.
- Rheinstein PH, Maxis MB. Regulation of OTC drug advertising: the FDA "prescription." .1 Am Pharm Assoc 1976;NS16:5054–.
- Kotler v, Armstrong G. Principles of marketing. 4th ed. Englewood Cliffs, NJ: Prentice-Hall, 1989.
- Resnik A, Stern BL. An analysis of information content in television ad-vertising..1 Market 1977;41:50–3.
- Rallapalli KC, Smith MC. OTC drug advertising: an analysis of its in-formation acntcnt.J Soc Admin Pharm 1994;11:139–47.
- Federal Reg I986;51(Apr):16138–49.
- The Tan Sheet 1995;19(3):8.
- Hussar DA. Editorial. Pharm Today 1996;2(5):5.